Date: 31-Aug-2019

Aurobindo Pharma arm forms JV in China

New Delhi: Drug firm Aurobindo Pharma on Friday said its arm Helix Healthcare B V, Netherlands has entered into an agreement with Chinese firm Shanghai LongJin Investment Company and Sveva Capitals, Hongkong to form a JV firm, Longxiang Pharma Taizhou Co Ltd in China. The joint venture is for development, manufacturing, marketing and sale of pharmaceutical products for China, excluding Taiwan, Hongkong and Macau, Aurobindo Pharma said in a filing to the BSE.